Martin Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Hold
4,113
1.14% 23
2026
Q1
$2.31M Sell
4,113
-46
-1% -$29.5K 1.46% 17
2025
Q4
$2.81M Buy
4,159
+45
+1% +$30.6K 1.65% 15
2025
Q3
$2.63M Buy
4,114
+1
+0% +$607 1.59% 16
2025
Q2
$2.21M Buy
4,113
+100
+2% +$47.8K 1.44% 19
2025
Q1
$1.69M Sell
4,013
-63
-2% -$27.4K 1.2% 25
2024
Q4
$1.69M Hold
4,076
1.09% 27
2024
Q3
$2.06M Buy
4,076
+13
+0.3% +$6.32K 1.47% 20
2024
Q2
$1.98M Sell
4,063
-54
-1% -$27.1K 1.48% 21
2024
Q1
$2.22M Hold
4,117
1.74% 18
2023
Q4
$2.29M Buy
4,117
+23
+0.6% +$10.8K 1.93% 14
2023
Q3
$1.79M Sell
4,094
-25
-0.6% -$12.5K 1.74% 15
2023
Q2
$2.07M Buy
4,119
+46
+1% +$22K 1.89% 14
2023
Q1
$2.04M Sell
4,073
-70
-2% -$33.5K 2.1% 12
2022
Q4
$1.69M Buy
4,143
+1,607
+63% +$624K 1.89% 16
2022
Q3
$826K Sell
2,536
-5,124
-67% -$1.88M 1.21% 26
2022
Q2
$2.69M Hold
7,660
2.37% 11
2022
Q1
$4.19M Buy
7,660
+20
+0.3% +$10.5K 2.87% 8
2021
Q4
$5.03M Buy
+7,640
New +$4.8M 3.11% 7

Other funds holding IDXX

Martin Capital Advisors's IDXX Position: Q2 2026 in Review

Martin Capital Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4,113 shares worth $2.17M. The position accounts for 1.14% of the portfolio, ranked #23.

Martin Capital Advisors first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.03M in Q4 2021. 487 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Martin Capital Advisors held 4,113 shares of Idexx Laboratories worth $2.17M as of Q2 2026.
  • Martin Capital Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 1.14% of Martin Capital Advisors's portfolio in Q2 2026, its #23 holding.
  • Martin Capital Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Martin Capital Advisors's Idexx Laboratories position peaked at $5.03M in Q4 2021.
  • 487 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Martin Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.